Нажмите на эту строку чтобы перейти к Новостям сайта "Русский врач"

Перейти
на сайт
журнала
"Врач"
Перейти на сайт журнала "Медицинская сестра"
Перейти на сайт журнала "Фармация"
Перейти на сайт журнала "Молекулярная медицина"
Перейти на сайт журнала "Вопросы биологической, медицинской и фармацевтической химии"
Журнал включен в российские и международные библиотечные и реферативные базы данных

ВАК (Россия)
РИНЦ (Россия)
Эко-Вектор (Россия)

ANXIOLYTIC ACTION OF OROSTACHYS SPINOSA DRY EXTRACT

DOI: https://doi.org/10.29296/25877313-2023-10-08
Issue: 
10
Year: 
2023

Ya.G. Razuvaeva
Dr.Sc. (Biol.), Senior Research Scientist,
Institute of General and Experimental Biology SB RAS (Ulan-Ude, Russia)
E-mail: tatur75@mail.ru
E.A. Bayandueva
Post-graduate Student,
Institute of General and Experimental Biology SB RAS (Ulan-Ude, Russia)
A.A. Toropova
Ph.D. (Biol.), Senior Research Scientist,
Institute of General and Experimental Biology SB RAS (Ulan-Ude, Russia)
I.G. Nikolaeva
Dr.Sc. (Pharm.), Senior Research Scientist,
Institute of General and Experimental Biology SB RAS (Ulan-Ude, Russia)

The study purpose: to evaluate the anxiolytic effect of the Orostachys spinosa dry extract. Material and methods. The studies were carried out on Wistar rats. An aqueous solution of the O. spinosa extract at doses of 50, 100 and 200 mg/kg was administered to the experimental groups animals for 14 days prior to testing. The anxiolytic effect of the O. spinosa extract was evaluated in the tests: "open field", "elevated plus maze", "light/dark chamber", "unmotivated aggression" and "conflict situation" according to Vogel. Results. It was found that the O. spinosa extract at doses of 100 and 200 mg/kg increases the vertical, horizontal activity and the index of the mink reflex in the "open field"; the entries number and the time into the open arms in the elevated plus maze; the transitions number and the time spent in the light section in the "light/dark chamber". Under conditions of "punishable behavior", the O. spinosa extract at a dose of 100 mg/kg exhibits anti-aggressive and anxiolytic effects. The studied extract reduces the anxiogenic effects of bicuculline and picrotoxin in the Vogel test. Conclusion. The O. spinosa dry extract has an anxiolytic effect, which is due to its stimulating effect on the GABAergic system.
Keywords: 
Orostachys spinosa dry extract
anxiolytic effect
white rats.
References: 
  1. Pine R., Fleming T., McCallum S., Sutcliffe K. The Effects of Casual Videogames on Anxiety, Depression, Stress, and Low Mood: A Systematic Review. Games for Health Journal. 2020; 9(4): 264. DOI:10.1089/g4h.2019.0132.
  2. Kotova O.V., Medvedev V.Je., Akarachkova E.S., Beljaev A.A. KOVID-19 i stress-svjazannye rasstrojstva. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2021; 121(2): 122–128. DOI:10.17116/jnevro2021121052122.
  3. Fathinezhad Z., Sewell R.D.E., Lorigooini Z., Rafieian-Kopaei M. Depression and treatment with effective herbs. Curr. Pharm. Des. 2019; 25 (6): 738–745. DOI: 10.2174/1381612825666190402105803.
  4. Speers A.B., Cabey K.A., Soumyanath A., Wright K.M. Effects of Withania somnifera (Ashwagandha) on stress and the stress-related neuropsychiatric disorders anxiety, depression, and insomnia. Curr. Neuropharmacol. 2021; 19(9): 1468-1495. doi: 10.2174/1570159X19666210712151556
  5. Nikolaeva I.G., Cybiktarova L.P., Nikolaeva G.G., Manzhigeev P.G. Fitohimicheskoe issledovanie nadzemnoj chasti gornokolosnika koljuchego. Voprosy obespechenija kachestva lekarstvennyh sredstv. 2018; 22(4): 5256.
  6. Nikolaeva I.G., Tsybiktarova L.P., Taraskin V.V., Radnaeva L.D., Tykheev Zh.A., Nikolaeva G.G. Manzhigeev P.G. Lipids from Orostachys spinose. Chemistry of Natural Compounds. 2018; 54(5): 961963. DOI:10.1007/s10600-018-2522-9.
  7. Budancev A.L., Lesiovskaja E.E. Dikorastushhie poleznye rastenija Rossii. SPb: SPFHA, 2001: 663.
  8. Shreter A.I. Lekarstvennaja flora Sovetskogo Dal'nego Vostoka. M.: Medicina, 1975: 328.
  9. Leventa A.I., Odinec A.D., Ohremchuk L.V., Usov L.A. Vlijanie izvlechenij iz gornokolosnika i rododendrona Adamsa na povedencheskie reakcii laboratornyh zhivotnyh. Sibirskij medicinskij zhurnal (Irkutsk). 2010; 95(4): 103105.
  10. Odinec A.D., Leventa A.I., Shhukin D.A., Shabaturova O.V. K antigipoksichekomu dejstviju preparatov iz rastitel'nogo syr'ja Bajkal'skoj Sibiri. Sibirskij medicinskij zhurnal (Irkutsk). 2011; 104(5): 112115.
  11. Odinec A.D., Usov L.A., Izatulin A.V., Leventa A.I., Shabaturova O.V. Vlijanie preparatov iz gornokolosnika koljuchego i rododendrona Adamsa na techenie stress-reakcii jeksperimental'nyh zhivotnyh. Bjulleten' VSNC SO RAMN. 2010; 76(6): 175181.
  12. Usov L.A., Leventa A.I., Odinec A.D. Anksioliticheskie i mnemotropnye jeffekty izvlechenij iz gornokolosnika i rododendrona Adamsa v jeksperimente na labora-tornyh zhivotnyh. Sibirskij medicinskij zhurnal (Irkutsk). 2010; 96(5): 125128.
  13. Patent 2784435. Sposob poluchenija sredstva, obladajushhego nejroprotektivnoj, immunomodulirujushhej aktivnost'ju. Nikolaeva I.G., Hobrakova V.B., Razuvaeva Ja.G., Nikolaeva G.G., Nikolaev S.M., Cybiktarova L.P., Toropova A.A., Bajandueva E.A.; zajavitel' i patentoobladatel' FGBUN IOJeB SO RAN. № 022113385; zajavl. 18.05.2022; opubl. 25.11.2022. Bjul. № 33.
  14. Rukovodstvo po provedeniju doklinicheskih issledovanij lekarstvennyh sredstv. Chast' pervaja. Pod red. A.N. Mironova. M.: Grif i K, 2012: 944.
  15. Razuvaeva Ja.G., Bajandueva E.A., Toropova A.A., Nikolaeva I.G. Ocenka protivoishemicheskogo dejstvija jekstrakta suhogo Orostachys spinosa pri bilateral'noj okkljuzii obshhih sonnyh arterij u belyh krys. Voprosy biologicheskoj, medicinskoj i farmacevticheskoj himii. 2022; 25(7): 38. DOI:10.29296/25877313-2022-07-01.
  16. Razuvaeva Ja.G., Harzheev D.V., Garmaev D.Je. Fitoterapija trevozhnyh rasstrojstv. Vestnik Burjatskogo gosudarstvennogo universiteta. Serija medicina, farmaciя. 2015; 12: 9195.
  17. Agraharam G., Girigoswami A., Girigoswami K. Myricetin. А multifunctional flavonol in biomedicine. Curr Pharmacol Rep. 2022; 8(1): 4861. DOI: 10.1007/s40495-021-00269-2.
  18. Gupta G., Siddiqui M.A., Khan M.M., Ajmal M., Ahsan R., Rahaman M.A., Ahmad M.A., Arshad M., Khushtar M. Current pharmacological trends on myricetin. Drug Res (Stuttg). 2020; 70(10): 448–454. DOI: 10.1055/a-1224-3625.
  19. Semwal D.K., Semwal R.B., Combrinck S., Viljoen A. Myricetin: a dietary molecule with diverse biological activities. Nutrients. 2016; 8(90). DOI: 10.3390/nu8020090.
  20. Song X., Tan L., Wang M., Ren C., Guo C., Yang B., Ren Y., Cao Z., Li Y., Pei J. Myricetin: a review of the most recent research. Biomedicine & Pharmacotherapy. 2021; 134: 111017. DOI: 10.1016/j.biopha.2020.111017.
  21. Jie L., Haitao X., Chao H., Jiashu L. Pharmacological actions of myricetin in the nervous system: a comprehensive review of preclinical studies in animals and cell models. Frontiers in Pharmacology. 2021; 12. DOI: 10.3389/fphar.2021.797298.
  22. Nabavi S.F., Braidy N., Gortzi O., Sobarzo-Sanchez E., Daglia M., Skalicka-Woźniak K., Nabavi S.M. Luteolin as an anti-inflammatory and neuroprotective agent: a brief review. Brain Research Bulletin. 2015; 119 (Part A): 111. DOI: 10.1016/j.brainresbull.2015.09.002.
  23. Qiao H., Zhang X., Zhu C., Dong L., Wang L., Zhang X., Xing Y., Wang C., Ji Y., Cao X. Luteolin downregulates TLR4, TLR5, NF-κB and p-p38MAPK expression, upregulates the p-ERK expression, and protects rat brains against focal ischemia. Brain Research. 2012; 1448:7181. DOI: 10.1016/j.brainres.2012.02.003.
  24. Qin L., Chen Z., Yang L., Shi H., Wu H., Zhang B., Zhang W., Xu Q., Huang F., Wu X. Luteolin-7-O-glucoside protects dopaminergic neurons by activating estrogen-receptor-mediated signaling pathway in MPTP-induced mice. Toxicology. 2019; 426: 152256. DOI: 10.1016/j.tox.2019.152256.
  25. Glenn J.M., Madero E.N., Bott N.T. Dietary protein and amino acid intake: links to the maintenance of cognitive health. Nutrients. 2019; 11: 1315. DOI: 10.3390/nu11061315.
  26. Tran P.V., Nguyen L.T.N., Yang H., Do P.H., Torii K., Putnam G.L., Chowdhury V.S., Furuse M. Intracerebroventricular injection of L-arginine and D-arginine induces different effects under an acute stressful condition. Biochem Biophys Res Commun. 2020; 533(4): 965970. DOI: 10.1016/j.bbrc.2020.09.111.
  27. Zhu Y., Wang R., Fan Z., Luo D., Cai G., Li X., Han J., Zhuo L., Zhang L., Zhang H., Li Y., Wu S. Taurine alleviates chronic social defeat stress-induced depression by protecting cortical neurons from dendritic spine loss. Cell Mol Neurobiol. 2023; 43(2): 827840. DOI: 10.1007/s10571-022-01218-3.